Copyright Reports & Markets. All rights reserved.

Global DNA Vaccines Sales Market Report 2019

Request for Sample of this report
Buy now

Table of Contents

    1 DNA Vaccines Market Overview 1

    • 1.1 DNA Vaccines Product Scope 1
    • 1.2 DNA Vaccines Segment by Type 1
      • 1.2.1 Global DNA Vaccines Sales Comparison by Types (2018-2025) 1
      • 1.2.2 Recombinant Protein Vaccine 2
      • 1.2.3 Gene-Based Vaccine 3
    • 1.3 DNA Vaccines Segment by Application 3
      • 1.3.1 Global DNA Vaccines Sales Comparison by Application (2014-2025) 3
      • 1.3.2 Human 4
      • 1.3.3 Animal 5
    • 1.4 DNA Vaccines Segment by Region 6
      • 1.4.1 Global DNA Vaccines Revenue Comparison by Region (2013-2025) 6
      • 1.4.2 North America DNA Vaccines Status and Prospect (2013-2025) 7
      • 1.4.3 Europe DNA Vaccines Status and Prospect (2013-2025) 8
      • 1.4.4 China DNA Vaccines Status and Prospect (2013-2025) 8
      • 1.4.5 Japan DNA Vaccines Status and Prospect (2013-2025) 9
      • 1.4.6 Southeast Asia DNA Vaccines Status and Prospect (2013-2025) 10
      • 1.4.7 India DNA Vaccines Status and Prospect (2013-2025) 11
    • 1.5 Global DNA Vaccines Sales and Revenue (2013-2025) 12
      • 1.5.1 Global DNA Vaccines Sales Growth Rate (2013-2025) 12
      • 1.5.2 Global DNA Vaccines Revenue Growth Rate (2013-2025) 13
    • 1.6 R & D 13
      • 1.6.1 Coridon Pty Ltd 15
      • 1.6.2 Inovio Pharmaceuticals 16

    2 DNA Vaccines by Company, Region, Type and Application 18

    • 2.1 Global DNA Vaccines Market Competition by Companies 18
      • 2.1.1 Global DNA Vaccines Sales Market Share of Key Companies (2017-2018) 18
      • 2.1.2 Global DNA Vaccines Revenue Market Share by Company (2017-2018) 19
    • 2.2 Global DNA Vaccines Sales and Revenue by Region 21
      • 2.2.1 Global DNA Vaccines Sales Market Share by Region (2013-2018) 21
      • 2.2.2 Global DNA Vaccines Revenue Market Share by Region (2013-2018) 22
    • 2.3 Global DNA Vaccines Sales and Revenue by Type 23
      • 2.3.1 Global DNA Vaccines Sales Market Share by Type (2013-2018) 23
      • 2.3.2 Global DNA Vaccines Revenue Market Share by Type (2013-2018) 24
    • 2.4 Global DNA Vaccines Sales by Application 26

    3 North America DNA Vaccines Sales, Revenue and Price 28

    • 3.1 North America DNA Vaccines Sales and Revenue (2013-2018) 28
      • 3.1.1 North America DNA Vaccines Sales Growth Rate (2013-2018) 28
      • 3.1.2 North America DNA Vaccines Revenue Growth Rate (2013-2018) 29
      • 3.1.3 North America DNA Vaccines Price Trend (2013-2018) 30
    • 3.2 North America DNA Vaccines Sales Market Share by Company 30
    • 3.3 North America DNA Vaccines Sales Market Share by Type 32
    • 3.4 North America DNA Vaccines Sales Market Share by Application 33

    4 Europe DNA Vaccines Sales, Revenue and Price 34

    • 4.1 Europe DNA Vaccines Sales and Value (2013-2018) 34
      • 4.1.1 Europe DNA Vaccines Sales Growth Rate (2013-2018) 34
      • 4.1.2 Europe DNA Vaccines Revenue Growth Rate (2013-2018) 35
      • 4.1.3 Europe DNA Vaccines Price Trend (2013-2018) 36
    • 4.2 Europe DNA Vaccines Sales Market Share by Company 36
    • 4.3 Europe DNA Vaccines Sales Market Share by Type 37
    • 4.4 Europe DNA Vaccines Sales Market Share by Application 38

    5 China DNA Vaccines Sales, Revenue and Price 40

    • 5.1 China DNA Vaccines Sales and Revenue (2013-2018) 40
      • 5.1.1 China DNA Vaccines Sales Growth Rate (2013-2018) 40
      • 5.1.2 China DNA Vaccines Revenue Growth Rate (2013-2018) 41
      • 5.1.3 China DNA Vaccines Price Trend (2013-2018) 42
    • 5.2 China DNA Vaccines Sales Market Share by Company 42
    • 5.3 China DNA Vaccines Sales Market Share by Type 43
    • 5.4 China DNA Vaccines Sales Market Share by Application 44

    6 Japan DNA Vaccines Sales, Revenue and Price 46

    • 6.1 Japan DNA Vaccines Sales and Value (2013-2018) 46
      • 6.1.1 Japan DNA Vaccines Sales Growth Rate (2013-2018) 46
      • 6.1.2 Japan DNA Vaccines Revenue Growth Rate (2013-2018) 47
      • 6.1.3 Japan DNA Vaccines Price Trend (2013-2018) 48
    • 6.2 Japan DNA Vaccines Sales Market Share by Company 48
    • 6.3 Japan DNA Vaccines Sales Market Share by Type 49
    • 6.4 Japan DNA Vaccines Sales Market Share by Application 50

    7 Southeast Asia DNA Vaccines Sales, Revenue and Price 52

    • 7.1 Southeast Asia DNA Vaccines Sales and Value (2013-2018) 52
      • 7.1.1 Southeast Asia DNA Vaccines Sales Growth Rate (2013-2018) 52
      • 7.1.2 Southeast Asia DNA Vaccines Revenue Growth Rate (2013-2018) 53
      • 7.1.3 Southeast Asia DNA Vaccines Price Trend (2013-2018) 54
    • 7.2 Southeast Asia DNA Vaccines Sales Market Share by Company 54
    • 7.3 Southeast Asia DNA Vaccines Sales Market Share by Type 55
    • 7.4 Southeast Asia DNA Vaccines Sales Market Share by Application 56

    8 India DNA Vaccines Sales, Revenue and Price 58

    • 8.1 India DNA Vaccines Sales and Value (2013-2018) 58
      • 8.1.1 India DNA Vaccines Sales Growth Rate (2013-2018) 58
      • 8.1.2 India DNA Vaccines Revenue Growth Rate (2013-2018) 59
      • 8.1.3 India DNA Vaccines Price Trend (2013-2018) 59
    • 8.2 India DNA Vaccines Sales Market Share by Company 60
    • 8.3 India DNA Vaccines Sales Market Share by Type 61
    • 8.4 India DNA Vaccines Sales Market Share by Application 62

    9 Analysis of DNA Vaccine Industry Key Manufacturers 64

    • 9.1 Merck 64
      • 9.1.1 Company Profile 64
      • 9.1.2 Product Information 65
      • 9.1.3 Sales, Price and Revenue 67
    • 9.2 GSK 67
      • 9.2.1 Company Profile 67
      • 9.2.2 Product Information 68
      • 9.2.3 Sales, Price and Revenue 69
    • 9.3 Sanofi 69
      • 9.3.1 Company Profile 69
      • 9.3.2 Product Information 71
      • 9.3.3 Sales, Price and Revenue 71
    • 9.4 Zoties 72
      • 9.4.1 Company Profile 72
      • 9.4.2 Product Information 73
      • 9.4.3 Sales, Price and Revenue 73
    • 9.5 Elanco 74
      • 9.5.1 Company Profile 74
      • 9.5.2 Product Information 75
      • 9.5.3 Sales, Price and Revenue 76
    • 9.6 Boehringer-Ingelheim (Merial) 76
      • 9.6.1 Company Profile 76
      • 9.6.2 Product Information 78
      • 9.6.3 Sales, Price and Revenue 78
    • 9.7 Indian Immunologicals 78
      • 9.7.1 Company Profile 78
      • 9.7.2 Product Information 79
      • 9.7.3 Sales, Price and Revenue 80
    • 9.8 Plumbline Life Sciences 80
      • 9.8.1 Company Profile 80
      • 9.8.2 Product Information 81
      • 9.8.3 Sales, Price and Revenue 81

    10 DNA Vaccines Manufacturing Cost Analysis 83

    • 10.1 DNA Vaccines Key Raw Materials Analysis 83
      • 10.1.1 Clinical Phase Costs 84
      • 10.1.2 Capitalized Costs 85
      • 10.1.3 Key Raw Materials 87
      • 10.1.4 Key Suppliers of Raw Materials 87
    • 10.2 Proportion of Manufacturing Cost Structure 89
      • 10.2.1 Labor Cost 89
      • 10.2.2 Other Costs Analysis 96
    • 10.3 Manufacturing Process Analysis of DNA Vaccines 101
    • 10.4 DNA Vaccines Industrial Chain Analysis 102

    11 Marketing Channel, Distributors and Customers 103

    • 11.1 Marketing Channel 103
    • 11.2 DNA Vaccines Distributors List 105
    • 11.3 DNA Vaccines Customers 107

    12 Market Dynamics 109

    • 12.1 Market Trends 109
    • 12.2 Opportunities 110
    • 12.3 Market Drivers 115
    • 12.4 Challenges 116
    • 12.5 Influence Factors 117
      • 12.5.1 GDP for Major Regions 117
      • 12.5.2 Population and Labor Considered for Forecast 119
      • 12.5.3 Disposable Income Considered for Forecast 121

    13 DNA Vaccines Market Forecast 123

    • 13.1 Global DNA Vaccines Sales, Revenue and Price Forecast 123
      • 13.1.1 Global DNA Vaccines Sales Growth Forecast (2019-2025) 123
      • 13.1.2 Global DNA Vaccines Revenue Growth Forecast (2019-2025) 124
      • 13.1.3 Global DNA Vaccines Price Trend Forecast (2019-2025) 125
    • 13.2 Global DNA Vaccines Forecast by Region 125
      • 13.2.1 Global DNA Vaccines Sales Growth Forecast by Region (2019-2025) 125
      • 13.2.2 Global DNA Vaccines Revenue Growth Forecast by Region (2019-2025) 126
      • 13.2.3 North America DNA Vaccines Sales, Revenue Growth Forecast (2019-2025) 128
      • 13.2.4 Europe DNA Vaccines Sales, Revenue Growth Rate Forecast (2019-2025) 129
      • 13.2.5 China DNA Vaccines Sales, Revenue Growth Forecast (2019-2025) 131
      • 13.2.6 Japan DNA Vaccines Sales, Revenue Growth Forecast (2019-2025) 132
      • 13.2.7 Southeast Asia DNA Vaccines Sales, Revenue Growth Forecast (2019-2025) 134
      • 13.2.8 India DNA Vaccines Sales, Revenue Growth Forecast (2019-2025) 135
    • 13.3 Global DNA Vaccines Forecast by Type 136
      • 13.3.1 Global DNA Vaccines Sales Forecast by Type (2019-2025) 136
      • 13.3.2 Global DNA Vaccines Revenue Forecast by Type (2019-2025) 137
    • 13.4 Global DNA Vaccines Forecast by Application 138

    14 Research Findings and Conclusion 140

      15 Methodology and Data Source 141

      • 15.1 Methodology/Research Approach 141
        • 15.1.1 Research Programs/Design 141
        • 15.1.2 Market Size Estimation 142
        • 15.1.3 Market Breakdown and Data Triangulation 143
      • 15.2 Data Source 145
        • 15.2.1 Secondary Sources 145
        • 15.2.2 Primary Sources 145
      • 15.3 Author List 147
      • 15.4 Disclaimer 148

      This report studies the global DNA Vaccines market status and forecast, categorizes the global DNA Vaccines market size (value & volume) by Key Companies, type, application, and region. This report focuses on the top players in United States, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

      In the last several years, Europe market of DNA Vaccine developed rapidly, with an average growth rate of 9.3%. In 2017, global sales revenue of DNA Vaccine is nearly 3430 M USD; the actual sale is about 74.8 million doses. Some of the major DNA vaccines include GlaxoSmithKline's Engerix-B, Twinrix, and Fendrix; Merck's Gardasil, and Recombivax HB; Protein Sciences Corporation's Flublok, etc. Currently, the researchers are engaged in developing genetic vaccines for humans. Animal genetic vaccines are already present in the market. These vaccines are third generation vaccines and contain DNA that codes for specific proteins from a pathogen.

      Top DNA Vaccines Players Covered in This report
      Merck
      GSK
      Sanofi
      Zoties
      Elanco
      Boehringer-Ingelheim
      Indian Immunologicals
      Plumbline Life Sciences

      Market Breakdown by Type
      Recombinant Protein Vaccine
      Gene-Based Vaccine

      Market Breakdown by Application
      Human
      Animal

      Market Breakdown by Regions
      North America
      Europe
      China
      Japan
      India
      Southeast Asia
      Other Regions
      Buy now